Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults

NCT04747392 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

BIOLOGICAL: SAL001
BIOLOGICAL: FORSTEO

Sponsor

Shenzhen Salubris Pharmaceuticals Co., Ltd.